Ukuthengisa Umgangatho ophezulu we-CAS 78-96-6 99% Amino-2-Propanol / Isopropanolamine / Monoisopropanolamine (MIPA)

Sihlala sikholelwa ukuba umlingiswa womntu uthatha isigqibo somgangatho ophezulu wemveliso, iinkcukacha zithatha isigqibo somgangatho ophezulu wemveliso, kunye ne-REALISTIC, ESEBENZAYO KUNYE NOBUCHULE bomoya wabasebenzi bokuthengisa okuPhezulu okuPhezulu kwe-CAS 78-96-6 99% Amino-2-Propanol / Isopropanolamine / Monoisopropanolamine (MIPA), Siza kwenza iinzame ezandisiweyo zokunceda abathengi basekhaya nabamazwe ngamazwe, kwaye sivelise inzuzo efanayo kunye nokuphumelela ngokubambisana phakathi kwethu.silindele ngolangazelelo intsebenziswano yakho ngokunyanisekileyo.
Sihlala sikholelwa ukuba umlingiswa womntu uthatha isigqibo somgangatho ophezulu weemveliso, iinkcukacha zithatha isigqibo somgangatho ophezulu wemveliso, kunye ne-REALISTIC, OKUFANELEKILEYO kunye nomoya we-INNOVATIVE crew.China Mipa kunye Monoisopropanolamine, Sidibanisa uyilo, ukuvelisa kunye nokuthumela ngaphandle kunye nabasebenzi abanobuchule abangaphezu kwe-100, inkqubo engqongqo yokulawula umgangatho kunye namava etekhnoloji.Sigcina ubudlelwane beshishini bexesha elide kunye nomthengisi kunye nabanikezeli benza amazwe angaphezu kwama-50, njenge-USA, UK, Canada, Europe kunye Afrika njl.

I-3′-Amino-2′-hydroxy-[1,1'-bipheny] -3-carboxylic acid isetyenziswa njengendawo ephakathi ye-Eltrombopag.
I-Eltrombopag, ephuhliswe yi-GlaxoSmithKline (GSK) e-UK kwaye kamva iphuhliswe ngokudibeneyo kunye ne-Novartis eSwitzerland, yeyokuqala kwaye ivunyiwe kuphela i-molecule encinci ye-non peptide TPO receptor agonist emhlabeni.I-Eltrombopag yavunywa yi-US FDA kwi-2008 yonyango lwe-idiopathic thrombocytopenic purpura (ITP), kunye ne-2014 yonyango lwe-anemia ye-aplastic enzima (AA).Ikwalichiza lokuqala elavunywa yi-US FDA kunyango lwe-AA kwiminyaka engama-30 yakutsha nje.
NgoDisemba 2012, i-US FDA ivume i-Eltrombopag yonyango lwe-thrombocytopenia kwizigulane ezine-hepatitis C engapheliyo (CHC), ukwenzela ukuba izigulane ze-hepatitis C ezine-prognosis embi ngenxa yokubala kweplatelet ephantsi inokuqala kwaye igcine unyango oluqhelekileyo lwe-interferon kwizifo zesibindi.NgoFebruwari3, 2014, i-GlaxoSmithKline yabhengeza ukuba i-FDA inike isiqinisekiso sonyango lwe-Eltrombopag kunyango lwe-hemopenia kwizigulane ezine-chemicalbook aplastic anemia (SAA) ezinzima ezingazange ziphendule ngokupheleleyo kwi-immunotherapy.Ngo-Agasti 24, i-2015, i-US FDA ivume i-Eltrombopag yonyango lwe-thrombocytopenia kubantu abadala kunye nabantwana abaneminyaka eyi-1 kunye nangaphezulu kunye ne-immune immune thrombocytopenia (ITP) abangenayo impendulo eyaneleyo kwi-corticosteroids, i-immunoglobulins okanye i-splenectomy.NgoJanuwari4, 2018, i-Eltrombopag yavunywa ukuba ibhalwe e-China kunyango lwe-immune immune thrombocytopenia (ITP).

Sihlala sikholelwa ukuba umlingiswa womntu uthatha isigqibo somgangatho ophezulu wemveliso, iinkcukacha zithatha isigqibo somgangatho ophezulu wemveliso, kunye ne-REALISTIC, ESEBENZAYO KUNYE NOBUCHULE bomoya wabasebenzi bokuthengisa okuPhezulu okuPhezulu kwe-CAS 78-96-6 99% Amino-2-Propanol / Isopropanolamine / Monoisopropanolamine (MIPA), Siza kwenza iinzame ezandisiweyo zokunceda abathengi basekhaya nabamazwe ngamazwe, kwaye sivelise inzuzo efanayo kunye nokuphumelela ngokubambisana phakathi kwethu.silindele ngolangazelelo intsebenziswano yakho ngokunyanisekileyo.
Ukuthengisa okushushuChina Mipa kunye Monoisopropanolamine, Sidibanisa uyilo, ukuvelisa kunye nokuthumela ngaphandle kunye nabasebenzi abanobuchule abangaphezu kwe-100, inkqubo engqongqo yokulawula umgangatho kunye namava etekhnoloji.Sigcina ubudlelwane beshishini bexesha elide kunye nomthengisi kunye nabanikezeli benza amazwe angaphezu kwama-50, njenge-USA, UK, Canada, Europe kunye Afrika njl.